Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial

导出原文传递

翻译打印收藏纠错

作者： Hunter, Samuel F. ^[1] ; Agius, Mark ^[2] ; Miller, Deborah M. ^[3] ; Cutter, Gary ^[4] ; Barbato, Luigi ^[5] ; McCague, Kevin ^[6] ; Meng, Xiangyi ; Agashivala, Neetu ; Chin, Peter ; Hollander, Eric

作者单位： Novartis Pharmaceut, 1 Hlth Plz, E Hanover, NJ 07936 USA ^[1] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA ^[2] Univ Alabama Birmingham, 1400 Univ Blvd, Birmingham, AL 35223 USA ^[3] Adv Neurosci Inst, 101 Forrest Crossing Blvd,Suite 103, Franklin, TN 37064 USA ^[4] Cleveland Clin Fdn, Mellen Ctr, 1950 East 89th St, Cleveland, OH 44195 USA ^[5] Albert Einstein Coll Med, 111 E 210th St, New York, NY 10467 USA ^[6]

关键词 BDI-II Depression Fingolimod Multiple sclerosis Patient-reported outcomes Satisfaction

发布时间 2017-08-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of the Neurological Sciences

2016年365卷

190-198页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial

Journal of the Neurological Sciences

相似文献

Journal of the Neurological Sciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial

Journal of the Neurological Sciences

相似文献

Journal of the Neurological Sciences

相关期刊

检索历史清除